Status:
COMPLETED
The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders
Lead Sponsor:
Medical University of Silesia
Conditions:
PRP
Temporomandibular Disorder
Eligibility:
All Genders
23-42 years
Phase:
PHASE2
PHASE3
Brief Summary
The Platelet-Rich Plasma intramuscular injections into the masseter and temporalis muscle were performed to reduce painful temporomandibular disorder symptoms,such as myalgia, myofascial pain and myof...
Detailed Description
Patients(n=120) attending The Department of Temporomandibular Disorders and Orthodontics at the Silesian Medical University Poland, Zabrze were enrolled to the study and randomly divided into one of t...
Eligibility Criteria
Inclusion
- presence of local myalgia, myofascial pain and myofascial pain with referral within masseter muscles according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) (II.1.A. 1, 2 and 3)
- patient's agreement for taking part into the research study
Exclusion
- patients being treated with or addicted to analgesic drugs and/or drugs that affect muscle function
- presence of contraindications for injection therapy
- patients being treated by neurologist for neurological disorders and/or neuropathic pain and/or headache
- patients after traumas to the head and neck region in the previous 2 years
- edentulous patients
- patients after radiotherapy
- presence of severe mental disorders
- pregnancy or lactation
- pain of dental origin
- presence of malignancy
- drug and/or alcohol addiction
- patients with needle phobia
Key Trial Info
Start Date :
December 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT03371888
Start Date
December 7 2017
End Date
January 1 2019
Last Update
January 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of TMD Silesian Medical University
Zabrze, Poland, 41-800